Cargando…
Micheliolide overcomes KLF4-mediated cisplatin resistance in breast cancer cells by downregulating glutathione
Micheliolide (MCL) is a promising novel compound with broad-spectrum anticancer activity. However, little is known regarding its action and mechanism in breast cancer. To explore the potential therapeutic application of MCL as a chemosensitivity modulator, this study investigated the effects of MCL...
Autores principales: | Jia, Yongsheng, Zhang, Chunze, Zhou, Liyan, Xu, Huijun, Shi, Yehui, Tong, Zhongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559251/ https://www.ncbi.nlm.nih.gov/pubmed/26356142 http://dx.doi.org/10.2147/OTT.S88661 |
Ejemplares similares
-
Dynamin-related protein 1 is involved in micheliolide-induced breast cancer cell death
por: Jia, Yongsheng, et al.
Publicado: (2015) -
Micheliolide suppresses LPS-induced neuroinflammatory responses
por: Sun, Zhaomeng, et al.
Publicado: (2017) -
Construction of differentially expressed Her-2 related lncRNA-mRNA-miRNA ceRNA network in Her-2 positive breast cancer
por: Jia, Xiaochen, et al.
Publicado: (2020) -
The mixed subtype has a worse prognosis than other histological subtypes: a retrospective analysis of 217 patients with metaplastic breast cancer
por: Hu, Jiayue, et al.
Publicado: (2023) -
Synthesis of Micheliolide Derivatives and Their Activities against AML Progenitor Cells
por: Ma, Wei-Wei, et al.
Publicado: (2013)